Journal profile · MEDICINE, GENERAL & INTERNAL
Patient Preference and Adherence
ISSN 1177-889X · Dove Medical Press Ltd. · ENGLAND · Founded 2007
Patient Preference and Adherence: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.57; JCR Q2 (journal website); fully open access; APC about USD 3,940; median 87 days to acceptance (126 articles, last 24 months); community-reported acceptance: easy; 328 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Patient Preference and Adherence is published by Dove Medical Press Ltd. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Medication Adherence and Compliance, Diabetes Management and Education and Patient-Provider Communication in Healthcare, together about 36.2% of its articles. Its main subfields are General Health Professions. (generated from OpenAlex topic counts and CAS ranking data)
Editor-in-Chief: Dr Johnny Chen Patient Preference and Adherence is an international, peer-reviewed, open access journal that focuses on the growing importance of patient preference and adherence throughout the therapeutic continuum. The role that patient satisfaction plays in developing new therapeutic modalities and compounds to optimize clinical outcomes for existing disease states is the major area of interest for the journal. The journal is characterized by the rapid reporting of original research, reviews, and clinical studies across all therapeutic areas. Patient Preference and Adherence will no longer consider meta-analyses for publication. Specific topics covered by the journal include: Patient satisfaction Treatment acceptability Treatment compliance Quality of life Health management modeling The journal will consider case reports and study protocols only if they make a valuable and original contribution to the literature. Basic research and animal-based studies are not suitable for this journal. Updated 5 August 2025
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, GENERAL & INTERNAL
Editor-in-chief Chen SurgeryPublisher website
Editorial board by country: 2 in mainland China (about 3%); most named United States 24, United Kingdom 16, Spain 5, Australia 5, Malaysia 4 (70 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Medication Adherence and ComplianceMedicine20.8%
- Diabetes Management and EducationMedicine8.5%
- Patient-Provider Communication in HealthcareHealth Professions6.9%
- Pharmaceutical Practices and Patient OutcomesMedicine6%
- Chronic Disease Management StrategiesMedicine5.4%
- Mobile Health and mHealth ApplicationsHealth Professions4.3%
- Cancer survivorship and careMedicine4.1%
- Patient Satisfaction in HealthcareHealth Professions3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Medicine, General & Internal | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Medicine, General & Internal | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Medicine, General & Internal | Zone 3 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · best quartile · 2025
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.57LetPub ·
- Impact factor (publisher) 2025
- 2.8Publisher website ·
- 5-year impact factor (publisher)
- 4Publisher website ·
- CiteScore 2026-06
- 4LetPub ·
- CiteScore (publisher) 2025
- 1.04Publisher website ·
- SJR 2026-06
- 0.69LetPub ·
- SNIP 2026-06
- 1.04LetPub ·
- h-index
- 37LetPub ·
- h-index
- 93OpenAlex ·
- i10-index
- 1,969OpenAlex ·
- 2-year mean citedness
- 2.52OpenAlex ·
- Self-citation rate
- 3.8%LetPub ·
- Share of gold OA articles
- 99.4%LetPub ·
Volume
- Articles per year
- 322LetPub ·
- Downloads per year (publisher)
- 344,738Publisher website ·
Articles by year OpenAlex count · 3,739 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 339 | 339 | 67 |
| 2025 | 328 | 328 | 777 |
| 2024 | 234 | 234 | 1,425 |
| 2023 | 304 | 304 | 2,688 |
| 2022 | 283 | 283 | 3,460 |
| 2021 | 268 | 268 | 4,348 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
87 daysMedian, submission to acceptance · P25–P75 67 days – 111 days
- Acceptance to online
- median 20 days (126 articles)
- Submission to online
- median 107 days
- Sample
- 126 articles with submission and acceptance dates (720 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 22%Publisher website ·
- Desk decision
- 49 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,940 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,836 | — | — | |
| LetPub | USD 3,300 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- case reportAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
- reviewAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
Policy excerpts from the journal's websitePeer review, Plagiarism, Trial registration / reporting guidelines
- Peer review
Member of and subscribes to the principles of COPE. Model summary
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Source ↗Publisher website ·- Plagiarism
Plagiarism checking via Crossref Similarity Check (iThenticate) on all submissions Model summary
Please be aware that Dove Medical Press checks ALL submitted manuscripts for plagiarism. We use Crossref Similarity Check (powered by iThenticate).
Source ↗Publisher website ·- Trial registration / reporting guidelines
Clinical trial registration required for trials involving human subjects Model summary
The section sets out the Dove Medical Press requirements for registration of any clinical trial involving human subjects.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Dove Medical Press Ltd.
- Country or region
- ENGLAND
- Language
- English
- Founded
- 2007
- ISSN
- 1177-889X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Patient Preference and Adherence
What CAS zone is Patient Preference and Adherence in?
In the 2025 upgraded edition of the CAS Journal Ranking, Patient Preference and Adherence is in Zone 3 of Medicine, and in Zone 3 of the minor category Medicine, General & Internal. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Patient Preference and Adherence?
The latest impact factor listed by LetPub is 2.57; CiteScore 4, h-index 93.
How long does peer review take at Patient Preference and Adherence?
Based on the dates recorded on 126 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 87 days (interquartile range 67–111 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 22%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Patient Preference and Adherence in?
The journal's website gives JCR Q2 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 3 of Medicine.
Where are the editorial board members of Patient Preference and Adherence based?
Of the 70 board members whose country the journal's board page names, 2 (about 3%) are in mainland China; the countries named most often are United States (24), United Kingdom (16) and Spain (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Patient Preference and Adherence?
According to LetPub and DOAJ records, Patient Preference and Adherence is indexed in SCIE, Scopus and DOAJ.
Is Patient Preference and Adherence open access, and what is the APC?
Patient Preference and Adherence is a fully open-access journal. APC about USD 3,940.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .